KBC Group NV Sells 1,235 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

KBC Group NV decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 423,504 shares of the medical equipment provider’s stock after selling 1,235 shares during the period. Intuitive Surgical makes up 0.6% of KBC Group NV’s investment portfolio, making the stock its 24th largest holding. KBC Group NV owned approximately 0.12% of Intuitive Surgical worth $221,052,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $584.05 on Monday. The business’s fifty day moving average is $547.16 and its 200 day moving average is $504.78. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market capitalization of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Activity

In related news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock valued at $22,059,506 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday. Finally, Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.